Clinical Development Of Biosimilars

This track includes Clinical trials on major diseases Risk management, and quality affairs, Case studies, and clinical models, Transgenic animals, Targeted cell line development, PK/PD studies, Toxicological studies, ethics maintained in clinical and preclinical studies, development difficulties and Aspects of genotoxicity tests. Biosimilar guidelines on the above mentioned topics are also to be thrown light upon at this biosimilars conference.

 

 

  • Biosimilars Clinical Trials
  • Toxicological studies
  • Clinical PK/PD studies
  • Targeted cell line development
  • Transgenic animals
  • Case studies, and clinical models
  • Clinical trials on major diseases
  • Biosimilars Clinical Studies
  • Aspects of genotoxicity tests
  • Case studies and clinical models
  • Biologics Product Life Cycle and Sustainable Market Returns

Related Conference of Clinical Development Of Biosimilars

April 10-11, 2024

10th international conference on Physiotherapy

Bangkok, Thailand

Clinical Development Of Biosimilars Conference Speakers